Paper17525742
IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.
Andrianifahanana M and 7 others. Oncogene, 2007. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Papers, record 17525742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation | Major topic |
| Interferon-gamma | Major topic |
| Mucins | Major topic |
| Pancreatic Neoplasms | Major topic |
| STAT1 Transcription Factor | Major topic |
| Up-Regulation | Major topic |
| Base Sequence | |
| Cell Line, Tumor | |
| Humans | |
| Mucin-4 | |
| Phosphorylation | |
| Promoter Regions, Genetic | |
| RNA Interference | |
| RNA, Small Interfering | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Transcriptional Activation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA078590 | NCI NIH HHS | United States | R01CA078590 | PubMed and NIH |
| CA78590 | NCI NIH HHS | United States | R01CA078590 | PubMed and NIH |
Source NIH RePORTER
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12923054 | DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. | Genes Dev | 2003 | https://conductscience.org/library/papers/12923054 | PubMed |
| 2 | 11408801 | Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors. | Oncology | 2001 | https://conductscience.org/library/papers/11408801 | PubMed |
| 3 | 12090430 | MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. | Am J Clin Pathol | 2002 | https://conductscience.org/library/papers/12090430 | PubMed |
| 4 | 10523304 | p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. | EMBO J | 1999 | https://conductscience.org/library/papers/10523304 | PubMed |
| 5 | 2199756 | Small-scale preparation of extracts from radiolabeled cells efficient in pre-mRNA splicing. | Methods Enzymol | 1990 | https://conductscience.org/library/papers/2199756 | PubMed |
| 6 | 17234748 | Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. | Cancer Res | 2007 | https://conductscience.org/library/papers/17234748 | PubMed |
| 7 | 10921891 | How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. | EMBO J | 2000 | https://conductscience.org/library/papers/10921891 | PubMed |
| 8 | 9143706 | Cellular responses to interferon-gamma. | Annu Rev Immunol | 1997 | https://conductscience.org/library/papers/9143706 | PubMed |
| 9 | 11418607 | Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11418607 | PubMed |
| 10 | 15705894 | Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. | Cancer Res | 2005 | https://conductscience.org/library/papers/15705894 | PubMed |
| 11 | 11751498 | Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11751498 | PubMed |
| 12 | 10851062 | Serine phosphorylation of STATs. | Oncogene | 2000 | https://conductscience.org/library/papers/10851062 | PubMed |
| 13 | 9287210 | STATs and gene regulation. | Science | 1997 | https://conductscience.org/library/papers/9287210 | PubMed |
| 14 | 8597888 | An overview of the interferon system: signal transduction and mechanisms of action. | Cancer Invest | 1996 | https://conductscience.org/library/papers/8597888 | PubMed |
| 15 | 10938282 | Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10938282 | PubMed |
| 16 | 8197455 | Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. | Science | 1994 | https://conductscience.org/library/papers/8197455 | PubMed |
| 17 | 10051633 | Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10051633 | PubMed |
| 18 | 15780933 | Structural bases of unphosphorylated STAT1 association and receptor binding. | Mol Cell | 2005 | https://conductscience.org/library/papers/15780933 | PubMed |
| 19 | 16397291 | Fast chromatin immunoprecipitation assay. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16397291 | PubMed |
| 20 | 14744777 | Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. | Cancer Res | 2004 | https://conductscience.org/library/papers/14744777 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42531039 | Aberrant mucin expression and keratinization distinguishing severe from mild asthma revealed by interpretable machine learning. | JCI Insight | 2026 | https://conductscience.org/library/papers/42531039 | PubMed |
| 42191046 | Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer. | Gastroenterology | 2026 | https://conductscience.org/library/papers/42191046 | PubMed |
| 40909948 | Dual regulation of gastrointestinal tumor progression by the IFN-γ/STAT1 pathway and prospects for targeted therapy. | Front Oncol | 2025 | https://conductscience.org/library/papers/40909948 | PubMed |
| 40741264 | STAT1/MUC4 activation promotes antimicrobial peptide production to reduce intestinal epithelium barrier injury caused by enteropathogenic Escherichia coli infection. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/40741264 | PubMed |
| 39086581 | 5-Fluorouracil-Loaded PLGA Declined Expression of Pro-Inflammatory Genes IL-9, IL-17A, IL-23 and IFN- y; in the HT-29 Colon Cancer Cell Line. | Rep Biochem Mol Biol | 2024 | https://conductscience.org/library/papers/39086581 | PubMed |
| 37674528 | Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation. | Cancer Res Commun | 2023 | https://conductscience.org/library/papers/37674528 | PubMed |
| 37637034 | Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/37637034 | PubMed |
| 37275859 | Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37275859 | PubMed |
| 35283421 | Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95/CD95L. | J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35283421 | PubMed |
| 34439340 | DUOX2, a New Biomarker for Disseminated Gastric Cancer's Response to Low Dose Radiation in Mice. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439340 | PubMed |
| 34128966 | Differential Effect of Proinflammatory Cytokines on Corneal and Conjunctival Epithelial Cell Mucins and Glycocalyx. | Transl Vis Sci Technol | 2021 | https://conductscience.org/library/papers/34128966 | PubMed |
| 34064525 | Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors. | Viruses | 2021 | https://conductscience.org/library/papers/34064525 | PubMed |
| 33005420 | Roles of IFN-γ in tumor progression and regression: a review. | Biomark Res | 2020 | https://conductscience.org/library/papers/33005420 | PubMed |
| 30524887 | Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30524887 | PubMed |
| 30236127 | Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. | J Transl Med | 2018 | https://conductscience.org/library/papers/30236127 | PubMed |
| 29780381 | Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. | Front Immunol | 2018 | https://conductscience.org/library/papers/29780381 | PubMed |
| 26784223 | Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease. | Nutrients | 2016 | https://conductscience.org/library/papers/26784223 | PubMed |
| 26526617 | The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. | Mol Oncol | 2016 | https://conductscience.org/library/papers/26526617 | PubMed |
| 25686822 | Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/25686822 | PubMed |
| 25624117 | Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. | Cancer Treat Rev | 2015 | https://conductscience.org/library/papers/25624117 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IRF1 | 3659 | PubTator's text mining | https://conductscience.org/library/genes/3659 | NCBI Gene |
| MUC4 | 4585 | PubTator's text mining | https://conductscience.org/library/genes/4585 | NCBI Gene |
| STAT1 | 6772 | PubTator's text mining | https://conductscience.org/library/genes/6772 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17525742
GET https://conductscience.org/api/papers/v1/17525742/references?page=2